Skip to main content
. Author manuscript; available in PMC: 2009 Jul 6.
Published in final edited form as: Neuromolecular Med. 2009 May 6;11(2):58–62. doi: 10.1007/s12017-009-8064-3

Figure 3.

Figure 3

Neither age at the onset of clinical disease nor age at death are correlated with total running distance or peak daily running distance prior to disease onset in mSOD1 mice. The 5 mice that ran the farthest total presymptomatic distance or that had the greatest peak daily running distance were considered high runners and the 5 mice that ran the least total distance or had the lowest peak daily running distance were considered low runners. There were no significant differences between low and high runners in either age at clinical onset or age at death.